Founder to depart biotech company
Millennium names top officers as part of major transition
Mark Levin, a biomedical engineer who helped propel the stock price of Millennium Pharmaceuticals Inc. to dizzying heights before it plunged, will today reveal his departure from the company he cofounded 12 years ago. (Full article: 518 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
